Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

HIV-1 drug resistance and genetic diversity in a cohort of people with HIV-1 in Nigeria.

AIDS (London, England) - 1 Jan 2022

Oluniyi Paul E, Ajogbasile Fehintola V, Zhou Shuntai, Fred-Akintunwa Iyanuoluwa, Polyak Christina S, Ake Julie A, Tovanabutra Sodsai, Iroezindu Michael, Rolland Morgane, Happi Christian T

Abstract excerpt

OBJECTIVE: This study was designed to provide information on the genetic diversity of HIV-1 and drug resistance mutations in Nigeria, as there is limited understanding of variants circulating in the country. METHODS: We used an advanced next-generation sequencing platform, Primer ID, to: investigate the presence of high and low abundance drug resistance mutations; characterize preexisting Integrase Strand...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Genotype
Share to HIV-1

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Resistance, Viral

Share to HIV Infections

Share to HIV Integrase

Share to HIV Integrase Inhibitors

Share to Mutation

Share to Nigeria

Source

Open in PubMed Open full text

Identifiers

PMID: 34628443
DOI: 10.1097/QAD.0000000000003098
PMCID: PMC8654252

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

HIV-1 drug resistance and genetic diversity in a cohort of people with HIV-1 in Nigeria.PMID 34628443Read ↗

Prevalence of HIV drug resistance in Nigeria: results from a cross-sectional, population-based survey of Nigerian adults with unsuppressed viral load.Semantic proximity Read ↗

Limited emergence of resistance to integrase strand transfer inhibitors (INSTIs) in ART-experienced participants failing dolutegravir-based antiretroviral therapy: a cross-sectional analysis of a Northeast Nigerian cohort.Semantic proximity Read ↗

Deep sequencing of HIV-1 reveals extensive subtype variation and drug resistance after failure of first-line antiretroviral regimens in Nigeria.Semantic proximity Read ↗

Drug resistance pattern of HIV type 1 isolates sampled in 2007 from therapy-naive pregnant women in North-Central Nigeria.Semantic proximity Read ↗

Limited emergence of resistance to Integrase strand transfer inhibitors (INSTIs) in HIV-experienced patients failing dolutegravir-based antiretroviral therapy: Cross-sectional analysis from a Northeast Nigerian cohortSemantic proximity Read ↗

Viral Genetic Diversity and Polymorphisms in a Cohort of HIV-1-Infected Patients Eligible for Initiation of Antiretroviral Therapy in Abuja, Nigeria.Semantic proximity Read ↗

Genetic diversity of human immunodeficiency virus-1 in Nigeria: 2002-2017 - systematic review and meta-analysis.Semantic proximity Read ↗

Genetic Diversity and Acquired Drug Resistance Mutations Detected by Deep Sequencing in Virologic Failures among Antiretroviral Treatment Experienced Human Immunodeficiency Virus-1 Patients in a Pastoralist Region of EthiopiaSemantic proximity Read ↗

Human Immunodeficiency Virus Type-1 Genetic Diversity and Drugs Resistance Mutations among People Living with HIV in Karachi, Pakistan.Semantic proximity Read ↗

HIV-1 genetic diversity and reverse transcriptase resistance mutations in Benin before dolutegravir era, West Africa.Semantic proximity Read ↗

Surveillance of Pretreatment Drug Resistance Among HIV-Infected Children in Ibadan, Nigeria.Semantic proximity Read ↗

Genetic diversity and drug resistance mutations of HIV-1 in Ghana: a systematic review of two decadesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.